MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2016 International Congress

    Greater incidence of depressive symptoms in atypical parkinsonism: Importance of early screening

    L. Almeida, B. Ahmed, R. Walz, S. De Jesus, A. Patterson, D. Martinez-Ramirez, D. Vaillancourt, D. Bowers, H. Ward, M.S. Okun, M. Armstrong, N. McFarland (Gainesville, FL, USA)

    Objective: To evaluate the incidence of depressive symptoms in Parkinsonian patients in a large cohort followed at a tertiary movement disorders center. Background: Despite relative…
  • 2016 International Congress

    Life satisfaction in Parkinson’s disease – associated factors

    K. Rosqvist, P. Hagell, P. Odin, S. Iwarsson, H. Ekström, M.H. Nilsson (Lund, Sweden)

    Objective: To identify factors associated with life satisfaction (LS) in people with Parkinson's disease (PD), including a specific focus on those with late stage PD.…
  • 2016 International Congress

    Relation between personality trait and depression in Parkinson’s disease

    A. Kumon, Y. Kobayashi, M. Saruwatari, N. Kawashima, K. Hasegawa (Sagamihara, Japan)

    Objective: 1. To investigate personality trait of patients with Parkinson's disease (PD). 2. To clarify the relationship between personality trait and depression in patients with…
  • 2016 International Congress

    Patient case reports supporting a long-term effect of sub-anesthetic ketamine infusion in reducing L-DOPA-induced dyskinesias

    S.J. Sherman, T. Falk (Tucson, AZ, USA)

    Objective: To evaluate possible long-term anti-dyskinetic activity of low-dose sub-anesthetic ketamine infusion from a retrospective chart review. Background: Repurposing drugs that have already been proven…
  • 2016 International Congress

    Long-term efficacy of safinamide on mood in Parkinsonian patients with fluctuations

    C. Cattaneo, E. Mueller, M. Sardina (Bresso, Italy)

    Objective: The present post-hoc analysis of the results of two pivotal trials (016 and 018) investigated the effects of safinamide 100 mg/day on mood in…
  • 2016 International Congress

    Impact of self-efficacy education on physical and psychosocial functioning in newly-diagnosed Parkinson patients

    D. Cook, C. McRae, R. Kumar (Englewood, CO, USA)

    Objective: To evaluate whether this program improves physical and psychosocial functioning in newly-diagnosed persons with Parkinson's disease (PWP) over the 12-month period of the intervention…
  • 2016 International Congress

    Profile of depressive symptoms in Parkinson’s disease patients and a population-based elderly cohort

    K. Hückelheim, E.J. Vollstedt, S. Tunc, J. Hampf, J. Graf, V. Tadic, C. Klein, M. Kasten (Lübeck, Germany)

    Objective: To examine the prevalences and profiles of depressive symptoms in Parkinson's disease (PD) patients and population-based control groups by using the Beck depression inventory.…
  • 2016 International Congress

    Motor and non-motor symptoms in Parkinson’s disease: Correlation and impact on quality of life and activities of daily living

    P. Bugalho, T. Lampreia, R. Miguel, M. Mendonça, A. Caetano, R. Barbosa (Lisbon, Portugal)

    Objective: To evaluate the prevalence, interrelation and impact on health related quality of life (HRQL) and Activities of daily Living (ADL) of motor (MS) and…
  • 2016 International Congress

    Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm

    B. Yuksel, F. Genc, A. Yaman, P. Dogan Ak, E. Ozaydin Goksu, A. Aybar, Y. Bicer Gomceli (Antalya, Turkey)

    Objective: Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial…
  • 2016 International Congress

    Impulse control disorder in early Parkinson’s disease: Follow-up study

    V. Markovic, I. Stankovic, I. Petrovic, T. Stojkovic, M. Jecmenica-Lukic, A. Tomic, V. Kostic (Belgrade, Serbia)

    Objective: To assess frequency of impulse control disorder (ICD) in a cohort of patients with early stage of Parkinson's disease (PD), to analyze clinical and…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25676 (not found)
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley